Literature DB >> 20558102

Fatal progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma treated with rituximab.

Jakob Paues1, Magnus Vrethem.   

Abstract

We report a case of progressive multifocal leukoencephalopathy (PML) in a woman with non-Hodgkin lymphoma treated with chemotherapy in combination with rituximab. She presented with rapid deterioration of vision and subsequently cognitive decline. Magnetic resonance imaging (MRI) of the brain raised the suspicion of PML. The first PCR analysis of the cerebrospinal fluid (CSF) was negative, but a second sample was positive for JC virus DNA. Anti-viral treatment was ineffective and the patient died 7 months after debut of symptoms. Our case emphasizes the importance of the awareness of PML in patients with progressive neurological symptoms treated with antilymphocytic drugs and that consecutive CSF analyses may be needed to detect the JC virus. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558102     DOI: 10.1016/j.jcv.2010.05.003

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  11 in total

1.  Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases.

Authors:  A Bharat; F Xie; J W Baddley; T Beukelman; L Chen; L Calabrese; E Delzell; C G Grijalva; N M Patkar; K Saag; K L Winthrop; J R Curtis
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

Review 2.  Posterior reversible encephalopathy syndrome in children with kidney disease.

Authors:  Cristina Gavrilovici; Ingrith Miron; Luminiţa Voroneanu; Silvia Bădărau; Magdalena Stârcea
Journal:  Int Urol Nephrol       Date:  2017-08-23       Impact factor: 2.370

Review 3.  The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects.

Authors:  Per Soelberg Sorensen; Morten Blinkenberg
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

Review 4.  Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).

Authors:  Amir Khalili; Michael Craigie; Martina Donadoni; Ilker Kudret Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

Review 5.  Posterior reversible encephalopathy syndrome in children with kidney diseases.

Authors:  Kenji Ishikura; Yuko Hamasaki; Tomoyuki Sakai; Hiroshi Hataya; Robert H Mak; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

Review 6.  Therapeutic antibodies against cancer.

Authors:  Mark J Adler; Dimiter S Dimitrov
Journal:  Hematol Oncol Clin North Am       Date:  2012-06       Impact factor: 3.722

7.  Progressive multifocal leukoencephalopathy during treatment with rituximab and CHOP chemotherapy in a patient with a diffuse large B-cell lymphoma.

Authors:  Tineke Sikkema; Wouter Jan Schuiling; Mels Hoogendoorn
Journal:  BMJ Case Rep       Date:  2013-01-25

Review 8.  Immunogenicity and other problems associated with the use of biopharmaceuticals.

Authors:  Michael G Tovey; Christophe Lallemand
Journal:  Ther Adv Drug Saf       Date:  2011-06

Review 9.  Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage Agents.

Authors:  Morten Blinkenberg; Per Soelberg Sørensen
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 6.497

10.  Progressive Multifocal Leukoencephalopathy with Negative JC Virus PCR following Treatment of Follicular Lymphoma: Implications for Biologics in the Era of Targeted Cancer Therapy.

Authors:  Kimberly A Silverio; Shyam A Patel
Journal:  Case Rep Oncol Med       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.